PubMed

Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Diabetes. 2006 Mar;55(3):780-4.PMID: 16505243 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.PMID: 18064330 [PubMed - indexed for MEDLINE]Related articles

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.

Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, Bernardo E, Zenni MM, Guzman LA, Bass TA, Costa MA.

Circulation. 2007 Feb 13;115(6):708-16. Epub 2007 Jan 29.PMID: 17261652 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.

Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.

Am J Cardiol. 2008 Aug 15;102(4):396-400. Epub 2008 May 22.PMID: 18678294 [PubMed - indexed for MEDLINE]Related articles

The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study.

Saw J, Madsen EH, Chan S, Maurer-Spurej E.

J Am Coll Cardiol. 2008 Dec 2;52(23):1826-33.PMID: 19038679 [PubMed - indexed for MEDLINE]Related articles

The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.

Dropinski J, Jakiela B, Sanak M, Wegrzyn W, Biernat M, Dziedzina S, Plutecka H, Szczeklik A.

Thromb Haemost. 2007 Jul;98(1):201-9.PMID: 17598014 [PubMed - indexed for MEDLINE]Related articles

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Diabetes. 2005 Aug;54(8):2430-5.PMID: 16046311 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.

Lee BK, Lee SW, Park SW, Lee SW, Park DW, Kim YH, Lee CW, Hong MK, Kim JJ, Jang S, Chi HS, Park SJ.

Am J Cardiol. 2007 Aug 15;100(4):610-4. Epub 2007 Jun 29.PMID: 17697815 [PubMed - indexed for MEDLINE]Related articles

P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.

Bierend A, Rau T, Maas R, Schwedhelm E, Böger RH.

Br J Clin Pharmacol. 2008 Apr;65(4):540-7. Epub 2007 Nov 8.PMID: 17995973 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.

Cuisset T, Frere C, Quilici J, Morange PE, Saut N, Lambert M, Camoin L, Vague IJ, Bonnet JL, Alessi MC.

Thromb Res. 2007;120(6):893-9. Epub 2007 Mar 6.PMID: 17337040 [PubMed - indexed for MEDLINE]Related articles

Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Am J Cardiol. 2006 Jan 1;97(1):38-43. Epub 2005 Nov 7.PMID: 16377281 [PubMed - indexed for MEDLINE]Related articles

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.

Angiolillo DJ, Bernardo E, Ramírez C, Costa MA, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Bass TA, Macaya C, Fernandez-Ortiz A.

J Am Coll Cardiol. 2006 Jul 18;48(2):298-304. Epub 2006 Jun 22.PMID: 16843179 [PubMed - indexed for MEDLINE]Related articles

ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay.

Schäfer A, Weinberger S, Flierl U, Eigenthaler M, Störk S, Walter U, Ertl G, Bauersachs J.

Thromb Haemost. 2008 Oct;100(4):618-25.PMID: 18841284 [PubMed - indexed for MEDLINE]Related articles

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C.

Thromb Res. 2005;116(6):491-7. Epub 2005 Apr 20.PMID: 16181985 [PubMed - indexed for MEDLINE]Related articles

Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.

Serebruany V, Pokov I, Kuliczkowski W, Chesebro J, Badimon J.

Thromb Haemost. 2008 Jul;100(1):76-82.PMID: 18612541 [PubMed - indexed for MEDLINE]Related articles

[Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation]

Morel O, Viellard C, Faure A, Jesel L, Ohlmann P, Desprez D, Chauvin M, Roul G, Grunebaum L, Bareiss P.

Ann Cardiol Angeiol (Paris). 2007 Jan;56(1):21-9. French. PMID: 17343035 [PubMed - indexed for MEDLINE]Related articles

Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.

Graff J, Harder S, Wahl O, Scheuermann EH, Gossmann J.

Clin Pharmacol Ther. 2005 Nov;78(5):468-76. Epub 2005 Sep 26.PMID: 16321613 [PubMed - indexed for MEDLINE]Related articles

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.

Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS.

J Am Coll Cardiol. 2006 Jan 3;47(1):27-33. Epub 2005 Dec 9.PMID: 16386660 [PubMed - indexed for MEDLINE]Related articles

Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease.

Lev EI, Arikan ME, Vaduganathan M, Alviar CL, Tellez A, Mathuria N, Builes A, Granada JF, del Conde I, Kleiman NS.

Am Heart J. 2007 Oct;154(4):694.e1-7.PMID: 17892993 [PubMed - indexed for MEDLINE]Related articles

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.

Eikelboom JW, Hankey GJ, Thom J, Claxton A, Yi Q, Gilmore G, Staton J, Barden A, Norman PE.

J Thromb Haemost. 2005 Dec;3(12):2649-55.PMID: 16359503 [PubMed - indexed for MEDLINE]Related articles